Navigation Links
CTi’s Technology Highly Applicable in “Frack Water” and Waste Water Treatment

Chatsworth, California (PRWEB) July 11, 2013

Cavitation Technologies, Inc. announced today that the Company will commence trial testing of it’s Cavitation Electrocoagulation System with several “frack water” and wastewater treatment facilities within the U.S.

CTi’s Electrocoagulation System provides an innovative and efficient solution for the treatment of wastewater. More importantly, because of the system’s low electricity requirements and miniaturization of needed power supplies, the system can dramatically reduce operating costs compared to conventional wastewater treatment methods.

Roman Gordon, the company’s CTO, added, “Our Cavitation waste water system has demonstrated it can dramatically minimize the presence of heavy metals, oil emulsions, fats, grease, bacteria, viruses, and cysts in an environmentally sound and cost-effective manner. Our Cavitation technology and Electrocoagulaiton process provides the opportunity to maximize the beneficial re-use of resource materials, minimize transportation and disposal costs, as well as their associated liabilities.”

Additionally, Gordon noted that the potential applications of CTi’s system are infinite, as waste water treatment plays a vital role in food, beverage, pharmaceutical, pulp and paper, textiles, manufacturing, marine industry, mining process water, municipal water management, and automotive uses. The Company plans to begin utilizing the system in fiscal 2014 and will identify strategic partners accordingly.

About CTI
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, robust devices and systems and develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement and water treatment. As an add-on to existing neutralization systems, the company’s patented NanoReactor™ allows refiners to significantly reduce both processing costs and the environmental impact, while also increasing the yield. More information is available at

The foregoing press release may contain forward-looking statements, including statements regarding, among other things, about the expectation of CTI's future business. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment, and the Company's performance. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Desmet Ballestra Will Install CTI’s System at Edible Oil Refinery in Ecuador
2. PathoGenetix to Debut New Genotyping Technology for Rapid Strain Typing at IAFP
3. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
4. TriMix for Travel Now Available at KRS Global Biotechnology
5. Official Opening of UKs Biggest Bioethanol Plant Using Praj Technology
6. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
7. iBio Pharmaceutical Technology Embraced by the Government of Brazil
8. Vinno Technology Co. Ltd Announced a Winner of the Renowned Platinum A' Design Award
9. City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall
10. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
11. Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
Breaking Biology News(10 mins):